These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33529425)

  • 1. Activation of EGFR-Aurora A induces loss of primary cilia in oral squamous cell carcinoma.
    Yin F; Chen Q; Shi Y; Xu H; Huang J; Qing M; Zhong L; Li J; Xie L; Zeng X
    Oral Dis; 2022 Apr; 28(3):621-630. PubMed ID: 33529425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of FAP in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
    Li R; Zhang R; Shi X; Jiao X; Li Y; Zhao Y; Liu T; Zhang C
    Int Dent J; 2024 Jun; 74(3):581-588. PubMed ID: 38278714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expressions of Interleukin-27 in Oral Lichen Planus, Oral Leukoplakia, and Oral Squamous Cell Carcinoma.
    Wang QM; Huang XY; Guan WQ
    Inflammation; 2022 Jun; 45(3):1023-1038. PubMed ID: 35064378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compositional and functional changes in the salivary microbiota related to oral leukoplakia and oral squamous cell carcinoma: a case control study.
    Lan Q; Zhang C; Hua H; Hu X
    BMC Oral Health; 2023 Dec; 23(1):1021. PubMed ID: 38115005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of PD-1/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma.
    Xu SB; Wang MY; Shi XZ; Wang Q; Yu M; Zhang W; Xu XH; Liu LK
    Oral Dis; 2023 Nov; 29(8):3268-3277. PubMed ID: 35921211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the response of normal oral mucosa, oral leukoplakia, oral squamous cell carcinoma-derived mesenchymal stem cells, and epithelial cells to photodynamic therapy.
    Guo Q; Ji X; Zhang L; Liu X; Wang Y; Liu Z; Jin J; Han Y; Liu H
    J Photochem Photobiol B; 2024 Jun; 255():112907. PubMed ID: 38677259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling.
    Huang Z; Rui X; Yi C; Chen Y; Chen R; Liang Y; Wang Y; Yao W; Xu X; Huang Z
    J Exp Clin Cancer Res; 2023 Mar; 42(1):60. PubMed ID: 36899380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cell-exosome-mediated matrix metalloproteinase 1 participates in oral leukoplakia and carcinogenesis by inducing angiogenesis.
    Li S; Han Y; Lu M; Liu Z; Jin J; Guo Q; Wang Y; Liu H
    J Oral Pathol Med; 2022 Aug; 51(7):638-648. PubMed ID: 35792829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of ADAM10 in oral squamous cell carcinoma with metastases.
    Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Kulicka P; Danilewicz M
    Pol J Pathol; 2018; 69(1):67-72. PubMed ID: 29895129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
    Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
    Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copy Number Alterations Predict Development of OSCC from Oral Leukoplakia.
    Cai X; Zhang J; Li L; Liu L; Tang M; Zhou X; Peng C; Li X; Chen X; Xu M; Zhang H; Wang J; Huang Y; Li T
    J Dent Res; 2024 Feb; 103(2):138-146. PubMed ID: 38217281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
    Cao J; Jin JQ; Deng DJ; Liu HW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal regulatory protein α associated with the progression of oral leukoplakia and oral squamous cell carcinoma regulates phenotype switch of macrophages.
    Ye X; Zhang J; Lu R; Zhou G
    Oncotarget; 2016 Dec; 7(49):81305-81321. PubMed ID: 27793032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DEC1: a potential biomarker of malignant transformation in oral leukoplakia.
    Mao T; Xiong H; Hu X; Hu Y; Wang C; Yang L; Huang D; Xia K; Su T
    Braz Oral Res; 2020; 34():e052. PubMed ID: 32578762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression Induced by Chronic Inflammation and the Progression to Oral Squamous Cell Carcinoma.
    Sun Y; Liu N; Guan X; Wu H; Sun Z; Zeng H
    Mediators Inflamm; 2016; 2016():5715719. PubMed ID: 28053372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear Epidermal Growth Factor Receptor Overexpression as a Survival Predictor in Oral Squamous Cell Carcinoma.
    Tarle M; Raguž M; Muller D; Lukšić I
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical Expression of Epidermal Growth Factor Receptor (EGFR) in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
    Aamir R; Rauf F; Iqbal F; Yousuf S; Rehman A; Sheikh AK; Muhammad S
    Appl Immunohistochem Mol Morphol; 2024 Mar; 32(3):157-162. PubMed ID: 38268382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical evaluation of galectin-3 expression in oral squamous cell carcinoma, oral leukoplakia and normal mucosa.
    Selvaraj FM; Joseph AP; Varun BR; Mony V; Siva Kumar TT
    Indian J Dent Res; 2022; 33(3):282-286. PubMed ID: 36656189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cells are involved in the induction of macrophage phenotypes in oral leukoplakia and squamous cell carcinoma-a preliminary report.
    Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M
    J Oral Pathol Med; 2018 Feb; 47(2):136-143. PubMed ID: 29108105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CXCL11-CXCR3A axis influences the infiltration of CD274 and IDO1 in oral squamous cell carcinoma.
    Wang X; Zhang J; Zhou G
    J Oral Pathol Med; 2021 Apr; 50(4):362-370. PubMed ID: 33187013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.